Production & Sales

Mallinckrodt to acquire Sucampo Pharmaceuticals for $1.2bn

Mallinckrodt has signed a deal to acquire US-based Sucampo Pharmaceuticals for about $1.2bn to add the latter’s constipation medication Amitiza (lubiprostone) and other commercial and development assets to its portfolio.

Drugmaker Teva to cut 14,000 jobs globally

Teva Pharmaceutical Industries said it will lay off 14,000 jobs globally as part of a two-year restructuring plan, aimed at boosting its business and financial performance.

Flexion Therapeutics to acquire novel and non-opioid asset for osteoarthritis of knee

Flexion Therapeutics has entered into a definitive agreement with GeneQuine Biotherapeutics GmbH to acquire the global rights to GQ-203.

Ardelyx signs license agreement with Fosun Pharma for tenapanor in China

Ardelyx has entered into a license agreement with Shanghai Fosun Pharmaceutical Industrial Development Company (Fosun Pharma) for tenapanor.

Arena, Everest Medicines partner for Ralinepag and Etrasimod in China

Arena Pharmaceuticals and Everest Medicines have entered into a development and commercialization partnership for ralinepag and etrasimod in mainland China, Taiwan, Hong Kong, Macau, and South Korea (the "Territories").

Melinta Therapeutics to buy The Medicines Company’s infectious disease business

Melinta Therapeutics has agreed to acquire the infectious disease business from The Medicines Company.

Fresenius Kabi to extend pharmaceutical manufacturing in North Carolina

The State of North Carolina and Fresenius Kabi have announced plans to expand the company's presence in Wilson, North Carolina.

Cerecor to acquire TRx Pharmaceuticals

Cerecor has entered into an agreement to TRx Pharmaceuticals and its subsidiary Zylera Pharmaceuticals.

Cardinal to divest drug distribution business in China to Shanghai Pharma

Cardinal Health, an Ohio-based health care services company has signed a deal to divest its drug distribution business in China to Shanghai Pharmaceuticals (Shanghai Pharma) for $557m.